Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$480.12
+1.23%
Mkt Cap $10.77B
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (31 analysts)
$705.67
Range $527.00 – $964.00
Implied Upside
+47.0%
Consensus $705.67 vs current $480.12